FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3089826204> ?p ?o ?g. }

• W3089826204 endingPage "375" @default.
• W3089826204 startingPage "369" @default.
• W3089826204 abstract "Abstract Purpose The aim of this study was to evaluate the efficacy of XEN ® Gel Stent implantation in the treatment of primary open‐angle glaucoma (POAG) and pseudoexfoliation glaucoma (XFG) regarding the reduction of intraocular pressure (IOP) and number of IOP‐lowering medications over 2 years. Methods In this retrospective, observational, single‐centre study, patients with POAG or XFG underwent implantation of the XEN ® Gel Stent with or without combined phacoemulsification. Changes in mean IOP, mean number of IOP‐lowering medications, number of postoperative interventions, complete or qualified surgical success rate (defined as IOP < 18 mmHg without or with IOP‐lowering medication, respectively) and complete surgical failure rate (defined as the necessity of a glaucoma‐related secondary surgical intervention or loss of light perception) were assessed 12 months (12M) and 24 months (24M) postoperatively. Results Seventy‐nine eyes of 63 patients with open‐angle glaucoma were included in the study (71% POAG, 29% XFG). Before surgery, mean IOP was 23.4 ± 7.9 mmHg. IOP was 14.6 ± 3.6 mmHg 12 months postoperatively (−31% from baseline, 95% CI −42% to −20%, n = 30, p < 0.001) and 14.8 ± 4.4 mmHg 24 months postoperatively (−29% from baseline, 95% CI −30% to −41%, n = 28, p < 0.001). Mean number of IOP‐lowering medications was significantly reduced from 2.7 ± 1.1 before surgery to 1.0 ± 1.2 (−69%, 95% CI −89% to 46%, p < 0.001) 12 months after surgery and 1.0 ± 1.2 (−64%, 95% CI −91% to −36%, p < 0.001) at 24 months after surgery. Complete surgical success was achieved in 39% (12M) and 34% (24M) of patients and qualified success in 29% (12M) and 27% (24M). 13 (16%) eyes were classified as complete surgical failure. In 62% of the patients needling procedures had to be performed. Conclusion The XEN ® Gel Stent is an efficacious minimal invasive glaucoma surgery for primary open‐angle and pseudoexfoliation glaucoma, resulting in significant reduction of IOP and a reduction in glaucoma medications from baseline in two‐third of treated patients with 2‐year follow‐up. Frequent follow‐up examinations were mandatory to identify early and late bleb failure and additional needling procedures were necessary to reestablish aqueous flow." @default.
• W3089826204 created "2020-10-08" @default.
• W3089826204 creator A5008784420 @default.
• W3089826204 creator A5009506838 @default.
• W3089826204 creator A5009628835 @default.
• W3089826204 creator A5046399945 @default.
• W3089826204 creator A5077974302 @default.
• W3089826204 date "2020-09-30" @default.
• W3089826204 modified "2023-10-18" @default.
• W3089826204 title "Two‐year outcomes of minimally invasive XEN Gel Stent implantation in primary open‐angle and pseudoexfoliation glaucoma" @default.
• W3089826204 cites W1878715772 @default.
• W3089826204 cites W1994586384 @default.
• W3089826204 cites W2007896505 @default.
• W3089826204 cites W2080493419 @default.
• W3089826204 cites W2085815830 @default.
• W3089826204 cites W2107002124 @default.
• W3089826204 cites W2119289070 @default.
• W3089826204 cites W2132365080 @default.
• W3089826204 cites W2160959025 @default.
• W3089826204 cites W2239213121 @default.
• W3089826204 cites W2541400883 @default.
• W3089826204 cites W2593721691 @default.
• W3089826204 cites W2612206133 @default.
• W3089826204 cites W2627019718 @default.
• W3089826204 cites W2745069984 @default.
• W3089826204 cites W2753586881 @default.
• W3089826204 cites W2782805530 @default.
• W3089826204 cites W2886150176 @default.
• W3089826204 cites W2892282958 @default.
• W3089826204 cites W2905975551 @default.
• W3089826204 cites W2912421564 @default.
• W3089826204 cites W2912968083 @default.
• W3089826204 cites W2937404019 @default.
• W3089826204 cites W2946563844 @default.
• W3089826204 cites W2948885891 @default.
• W3089826204 cites W2983467291 @default.
• W3089826204 doi "https://doi.org/10.1111/aos.14627" @default.
• W3089826204 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8359400" @default.
• W3089826204 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32996702" @default.
• W3089826204 hasPublicationYear "2020" @default.
• W3089826204 type Work @default.
• W3089826204 sameAs 3089826204 @default.
• W3089826204 citedByCount "20" @default.
• W3089826204 countsByYear W30898262042021 @default.
• W3089826204 countsByYear W30898262042022 @default.
• W3089826204 countsByYear W30898262042023 @default.
• W3089826204 crossrefType "journal-article" @default.
• W3089826204 hasAuthorship W3089826204A5008784420 @default.
• W3089826204 hasAuthorship W3089826204A5009506838 @default.
• W3089826204 hasAuthorship W3089826204A5009628835 @default.
• W3089826204 hasAuthorship W3089826204A5046399945 @default.
• W3089826204 hasAuthorship W3089826204A5077974302 @default.
• W3089826204 hasBestOaLocation W30898262041 @default.
• W3089826204 hasConcept C118487528 @default.
• W3089826204 hasConcept C141071460 @default.
• W3089826204 hasConcept C2776508836 @default.
• W3089826204 hasConcept C2778257484 @default.
• W3089826204 hasConcept C2778527774 @default.
• W3089826204 hasConcept C2778583881 @default.
• W3089826204 hasConcept C2780186721 @default.
• W3089826204 hasConcept C2781092963 @default.
• W3089826204 hasConcept C2781104129 @default.
• W3089826204 hasConcept C2781121420 @default.
• W3089826204 hasConcept C2908569227 @default.
• W3089826204 hasConcept C2991803831 @default.
• W3089826204 hasConcept C71924100 @default.
• W3089826204 hasConceptScore W3089826204C118487528 @default.
• W3089826204 hasConceptScore W3089826204C141071460 @default.
• W3089826204 hasConceptScore W3089826204C2776508836 @default.
• W3089826204 hasConceptScore W3089826204C2778257484 @default.
• W3089826204 hasConceptScore W3089826204C2778527774 @default.
• W3089826204 hasConceptScore W3089826204C2778583881 @default.
• W3089826204 hasConceptScore W3089826204C2780186721 @default.
• W3089826204 hasConceptScore W3089826204C2781092963 @default.
• W3089826204 hasConceptScore W3089826204C2781104129 @default.
• W3089826204 hasConceptScore W3089826204C2781121420 @default.
• W3089826204 hasConceptScore W3089826204C2908569227 @default.
• W3089826204 hasConceptScore W3089826204C2991803831 @default.
• W3089826204 hasConceptScore W3089826204C71924100 @default.
• W3089826204 hasIssue "4" @default.
• W3089826204 hasLocation W30898262041 @default.
• W3089826204 hasLocation W30898262042 @default.
• W3089826204 hasLocation W30898262043 @default.
• W3089826204 hasOpenAccess W3089826204 @default.
• W3089826204 hasPrimaryLocation W30898262041 @default.
• W3089826204 hasRelatedWork W2022049485 @default.
• W3089826204 hasRelatedWork W2419155108 @default.
• W3089826204 hasRelatedWork W2752005099 @default.
• W3089826204 hasRelatedWork W2762781727 @default.
• W3089826204 hasRelatedWork W2781673216 @default.
• W3089826204 hasRelatedWork W2918298090 @default.
• W3089826204 hasRelatedWork W3013180754 @default.
• W3089826204 hasRelatedWork W3114344278 @default.
• W3089826204 hasRelatedWork W4205354443 @default.
• W3089826204 hasRelatedWork W4321610417 @default.
• W3089826204 hasVolume "99" @default.
• W3089826204 isParatext "false" @default.
• W3089826204 isRetracted "false" @default.

• next